Literature DB >> 23001046

Surgical management of pelvic organ prolapse and uterine descent in the Netherlands.

R J Detollenaere1, J den Boon, K B Kluivers, M E Vierhout, H W F van Eijndhoven.   

Abstract

INTRODUCTION AND HYPOTHESIS: To evaluate current practice in the surgical treatment of uterine descent among members of the Dutch Urogynecological Society and to analyze possible trends in the surgical treatment of pelvic organ prolapse in the Netherlands during the last decade.
METHODS: A questionnaire, including case scenarios, was sent to the members of the Dutch Urogynecological Society. Using a nationwide registry from the Netherlands, we assessed the number and type of surgical procedures performed for pelvic organ prolapse between 1997 and 2009.
RESULTS: The response rate was 73%, with 161 questionnaires completed. Vaginal hysterectomy, sacrospinous hysteropexy, and the Manchester Fothergill procedure were the most frequently performed surgical interventions for uterine descent. In the case of lower stage uterine descent, uterus preservation was preferred, but in the case of higher stage there was wide variation. Two thirds of the respondents stated that in recent years they tended to save the uterus more often. The registered number of hospital admissions for uterine descent increased by 30% between 1997 and 2009 and the number of surgical procedures almost doubled. The number of vaginal hysterectomies performed because of uterine descent increased by only 15% in this period.
CONCLUSIONS: In the Netherlands, surgical policy in the case of uterine descent is very variable, with no clear preference for either hysterectomy or uterus preservation. There was a high increase in hospital admissions and pelvic organ prolapse procedures in the last decade. The number of vaginal hysterectomies performed because of uterine descent did not follow this change, which reflects a trend toward preserving the uterus.

Mesh:

Year:  2012        PMID: 23001046     DOI: 10.1007/s00192-012-1934-5

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  22 in total

1.  A randomised controlled trial comparing abdominal and vaginal prolapse surgery: effects on urogenital function.

Authors:  Jan-Paul W R Roovers; C Huub van der Vaart; Johanna G van der Bom; Jules H Schagen van Leeuwen; Piet C Scholten; A Peter M Heintz
Journal:  BJOG       Date:  2004-01       Impact factor: 6.531

Review 2.  [Uterus preserving surgery versus vaginal hysterectomy in treatment of uterine descent: a systematic review].

Authors:  Renée J Detollenaere; Jan den Boon; Mark E Vierhout; Hugo W F van Eijndhoven
Journal:  Ned Tijdschr Geneeskd       Date:  2011

3.  The effectiveness of the sacrospinous hysteropexy for the primary treatment of uterovaginal prolapse.

Authors:  Viviane Dietz; Joyce de Jong; Marieke Huisman; Steven Schraffordt Koops; Peter Heintz; Huub van der Vaart
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-03-24

4.  The UK national prolapse survey: 5 years on.

Authors:  Swati Jha; Paul Moran
Journal:  Int Urogynecol J       Date:  2011-02-22       Impact factor: 2.894

5.  A randomized comparison of post-operative pain, quality of life, and physical performance during the first 6 weeks after abdominal or vaginal surgical correction of descensus uteri.

Authors:  J P W R Roovers; J G van der Bom; C H van der Vaart; J H Schagen van Leeuwen; P C Scholten; A P M Heintz
Journal:  Neurourol Urodyn       Date:  2005       Impact factor: 2.696

6.  Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.

Authors:  A L Olsen; V J Smith; J O Bergstrom; J C Colling; A L Clark
Journal:  Obstet Gynecol       Date:  1997-04       Impact factor: 7.661

7.  Uterus conserving prolapse surgery--what is the chance of missing a malignancy?

Authors:  Arasee Renganathan; Robin Edwards; Jonathan R A Duckett
Journal:  Int Urogynecol J       Date:  2010-02-05       Impact factor: 2.894

8.  Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study.

Authors:  Daniel Altman; Fredrik Granath; Sven Cnattingius; Christian Falconer
Journal:  Lancet       Date:  2007-10-27       Impact factor: 79.321

9.  The prevalence of pelvic organ prolapse symptoms and signs and their relation with bladder and bowel disorders in a general female population.

Authors:  Marijke C Ph Slieker-ten Hove; Annelies L Pool-Goudzwaard; Marinus J C Eijkemans; Regine P M Steegers-Theunissen; Curt W Burger; Mark E Vierhout
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05-15

10.  Functional outcome after sacrospinous hysteropexy for uterine descensus.

Authors:  Viviane Dietz; Marieke Huisman; Joyce M de Jong; Peter M Heintz; Carl H van der Vaart
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06
View more
  8 in total

1.  Practice pattern variation in surgical management of pelvic organ prolapse and urinary incontinence in The Netherlands.

Authors:  Mèlanie N van IJsselmuiden; Renée J Detollenaere; Maaike Y Kampen; Marian K Engberts; Hugo W F van Eijndhoven
Journal:  Int Urogynecol J       Date:  2015-07-06       Impact factor: 2.894

2.  Pelvic organ prolapse surgical management in Portugal and FDA safety communication have an impact on vaginal mesh.

Authors:  Teresa Mascarenhas; Miguel Mascarenhas-Saraiva; Amélia Ricon-Ferraz; Paula Nogueira; Fernando Lopes; Alberto Freitas
Journal:  Int Urogynecol J       Date:  2014-08-16       Impact factor: 2.894

3.  Vaginal cystocele repair and hysteropexy in women with anterior and central compartment prolapse: efficacy and safety after 30 months of follow-up.

Authors:  Maurizio Serati; Andrea Braga; Simona Cantaluppi; Giorgio Caccia; Fabio Ghezzi; Paola Sorice
Journal:  Int Urogynecol J       Date:  2017-10-24       Impact factor: 2.894

4.  Practice pattern variation: treatment of pelvic organ prolapse in The Netherlands.

Authors:  Rosa A Enklaar; Mèlanie N van IJsselmuiden; Joanna IntHout; Stefan J H Haan; Olivier G A M Rijssenbeek; Rolf H Bremmer; Hugo W F van Eijndhoven
Journal:  Int Urogynecol J       Date:  2021-09-06       Impact factor: 1.932

5.  Sacrospinous hysteropexy versus vaginal hysterectomy with suspension of the uterosacral ligaments in women with uterine prolapse stage 2 or higher: multicentre randomised non-inferiority trial.

Authors:  Renée J Detollenaere; Jan den Boon; Jelle Stekelenburg; Joanna IntHout; Mark E Vierhout; Kirsten B Kluivers; Hugo W F van Eijndhoven
Journal:  BMJ       Date:  2015-07-23

6.  Cervical amputation versus vaginal hysterectomy: a population-based register study.

Authors:  Ida Bergman; Marie Westergren Söderberg; Anders Kjaeldgaard; Marion Ek
Journal:  Int Urogynecol J       Date:  2016-08-16       Impact factor: 2.894

7.  Evaluation of two vaginal, uterus sparing operations for pelvic organ prolapse: modified Manchester operation (MM) and sacrospinous hysteropexy (SSH), a study protocol for a multicentre randomized non-inferiority trial (the SAM study).

Authors:  Sascha F M Schulten; Rosa A Enklaar; Kirsten B Kluivers; Sanne A L van Leijsen; Marijke C Jansen-van der Weide; Eddy M M Adang; Jeroen van Bavel; Heleen van Dongen; Maaike B E Gerritse; Iris van Gestel; G G Alec Malmberg; Ronald J C Mouw; Deliana A van Rumpt-van de Geest; Wilbert A Spaans; Annemarie van der Steen; Jelle Stekelenburg; E Stella M Tiersma; Anneke C Verkleij-Hagoort; Astrid Vollebregt; Chantal B M Wingen; Mirjam Weemhoff; Hugo W F van Eijndhoven
Journal:  BMC Womens Health       Date:  2019-04-02       Impact factor: 2.809

8.  Gynecologists' perspectives on two types of uterus-preserving surgical repair of uterine descent; sacrospinous hysteropexy versus modified Manchester.

Authors:  Rosa A Enklaar; Brigitte A B Essers; Leanne Ter Horst; Kirsten B Kluivers; Mirjam Weemhoff
Journal:  Int Urogynecol J       Date:  2020-10-26       Impact factor: 2.894

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.